Lerkamen tabs 10mg #60
- $35.90
- 3 or more $35.50
- Availability:In Stock
Lerkamen user manualReed more and buy Lerkamen on this pageTo buy Lerkamen 20mg just contact usCompositionThe tablet contains 10 or 20 mg of lercanidipine hydrochloride.Additional components: povidone K30, lactose monohydrate, sod..
Tags: tabs
Lerkamen user manual
Reed more and buy Lerkamen on this page
To buy Lerkamen 20mg just contact us
Composition
The tablet contains 10 or 20 mg of lercanidipine hydrochloride.
Additional components: povidone K30, lactose monohydrate, sodium carboxymethyl starch, cellulose, magnesium stearate. Each tablet is coated with a special coating, which includes: iron oxide, titanium dioxide, talc, opadrai and macrogol.
Form of issue
The drug is only available in tablet form. Dosage of the drug: 10 and 20 mg of the active substance. The blister can contain 7 or 10 tablets. Number of tablets in a cardboard bundle: 7, 14, 28, 35, 42, 50, 56, 60, 90, 98 or 100 pcs.
pharmachologic effect
Tablets have a pronounced hypotensive effect. The mechanism of action is based on the selective blocking of calcium receptors. Lercanidipine is able to slow the flow of calcium ions in the smooth muscle tissue and cardiomyocytes.
Lerkamen 20 reduces the overall peripheral vascular resistance and gradually widens the lumen of the vessels, preventing the development of reflex tachycardia and collapse. The drug does not have a negative inotropic effect.
Pharmacodynamics and pharmacokinetics
Lerkamen 10 is well absorbed in the digestive system. The maximum plasma concentration is recorded after 1.5-3 hours. Up to 98% of the active substance binds to plasma proteins.
Biological availability of the drug increases after eating, which is why it is recommended to take tablets on an empty stomach. With increasing doses, increased bioavailability is noted. Initially, the drug is metabolized in the hepatic system, which explains the low absolute bioavailability - 10%.
The hypotensive effect is observed during the day. The active component is excreted through the renal system; the elimination half-life is 10 hours.
Indications for use
Lercanidipine is prescribed to patients suffering from an essential form of arterial hypertension (severity: mild and moderate).
Contraindications
heart failure;
obstruction of vessels emerging from the left ventricle;
individual hypersensitivity to lercanidipine;
lactase insufficiency;
pregnancy;
an unstable form of angina pectoris;
acute myocardial infarction;
syndrome of weakness of the sinus node (in patients without a pacemaker);
lactation;
the age limit is 18 years.
Side effects
Nervous system:
migraine;
dizziness;
disturbance of sleep and wakefulness.
The digestive tract:
stool disorders;
gastralgia;
dyspepsia (vomiting, nausea);
increase of ALT, AST;
disturbance of digestion of food.
The cardiovascular system:
uncomfortable sensations behind the sternum;
increased heart rate;
increased attacks of angina pectoris;
a drop in blood pressure;
pain behind the sternum.
Also possible allergic responses, frequent urination, the development of polyuria, swelling, hyperemia, gingival hyperplasia, muscle pain.
Instructions for use of Lerkamen (Method and dosage)
Tablets are intended for oral administration. Do not grind the preparation, damage the protective shell. The effectiveness of the drug increases with the use of lercanidipine on an empty stomach. The duration of therapy is determined by the doctor.
Instructions for use Lerkamen 10: The tablet is taken 1 time every 24 hours. With insufficient reduction in blood pressure after 14 days, you can go to a single dose of 20 mg.
Instructions for Lerkamen 20: tablets washed down with water, on an empty stomach. With an increase in the dose of the drug (more than 20 mg per day), an increase in the hypotensive effect is not observed, but an increase in the frequency and severity of unwanted side reactions is recorded.
If the drug is ineffective in the therapy of arterial hypertension, the appointment of additional antihypertensive drugs from other pharmacological groups is recommended.
Overdose
There is a drop in blood pressure, drowsiness, ischemic changes in the tissues of the myocardium, nausea, development of cardiogenic shock. Recommended induction of vomiting, the appointment of laxatives, enterosorbents. In severe intoxication appoint dopamine, catecholamines, diuretics. Possible administration of atropine with the development of bradycardia, the fall of blood pressure and loss of consciousness. Treatment is carried out in a hospital. Hemodialysis has not proved its effectiveness.
Interaction
Absorption of the medication is enhanced by the treatment with midazolam. Inductors CYP3A4, ethanol, cyclosporine and grapefruit juice are categorically contraindicated when taking Lerkamen.
Caution is required when taking high doses of cimetidine (more than 800 mg).
Bioavailability of the active substance increases simultaneously with an increase in the negative inotropic effect during therapy with beta-blockers.
Required correction of the dose of digoxin after the initiation of lercanidipine therapy is required.
To reduce the risk of negative interaction, it is necessary to maintain a 10-hour window when taking simvastatin and lercanidipine.
Terms of sale
To buy Lerkamen the prescription is not required.
Storage conditions
The temperature is not higher than 25 degrees.
Shelf life - 3 years.
special instructions
The drug can affect the speed of the psychomotor reaction.
In pregnancy and lactation
Lerkamen is contraindicated in pregnant women, during lactation.
Reviews about Lerkamen (general view)
Thematic portals and medical forums, where patients share their impressions of taking medications, contain only positive feedback.
Reviews for Lerkamen 10: the drug is well tolerated and stabilizes the pressure after 2 weeks of regular use in patients with arterial hypertension of the 1st degree.
Reviews about Lerkamen 20: the incidence of adverse reactions is low, the medication is considered highly effective in the treatment of hypertension of 2,3 degrees in combination with other antihypertensive drugs.